Quent Capital, LLC Immunity Bio, Inc. Transaction History

Quent Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 14, 2024	SELL	$1.25 - $5.21 $6 - $26	-5 Reduced 0.27%	1,824 $9,000
Q4 2023 Jan 19, 2024	SELL	$1.25 - $5.21 $6 - $26	-5 Reduced 0.27%	1,824 $9,000
Q3 2023 Jun 14, 2024	BUY	$1.29 - $3.1 $1,795 - $4,315	1,392 Added 318.54%	1,829 $3,000
Q3 2023 Oct 10, 2023	BUY	$1.29 - $3.1 $1,795 - $4,315	1,392 Added 318.54%	1,829 $3,000
Q2 2023 Jun 14, 2024	BUY	$1.53 - $6.41 $53 - $224	35 Added 8.71%	437 $1,000
Q2 2023 Jul 10, 2023	BUY	$1.53 - $6.41 $53 - $224	35 Added 8.71%	437 $1,000
Q1 2023 Jun 14, 2024	SELL	$1.35 - $4.78 $1,919 - $6,797	-1,422 Reduced 77.96%	402 $0
Q1 2023 Apr 05, 2023	BUY	$1.35 - $4.78 $120 - $425	89 Added 28.43%	402 $0
Q4 2022 Jan 19, 2023	BUY	$4.35 - $6.77 $1,361 - $2,119	313 New	313 $0

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Quent Capital, LLC with notifications on news.